Cargando…
Comprehensive cross‐platform comparison of methods for non‐invasive EGFR mutation testing: results of the RING observational trial
Several platforms for noninvasive EGFR testing are currently used in the clinical setting with sensitivities ranging from 30% to 100%. Prospective studies evaluating agreement and sources for discordant results remain lacking. Herein, seven methodologies including two next‐generation sequencing (NGS...
Autores principales: | Romero, Atocha, Jantus‐Lewintre, Eloisa, García‐Peláez, Beatriz, Royuela, Ana, Insa, Amelia, Cruz, Patricia, Collazo, Ana, Pérez Altozano, Javier, Vidal, Oscar Juan, Diz, Pilar, Cobo, Manuel, Hernández, Berta, Vázquez Estevez, Sergio, Benítez, Gretel, Guirado, Maria, Majem, Margarita, Bernabé, Reyes, Ortega, Ana Laura, Blasco, Ana, Bosch‐Barrera, Joaquim, Jurado, Jose M., García González, Jorge, Viteri, Santiago, Garcia Giron, Carlos, Massutí, Bartomeu, Lopez Martín, Ana, Rodriguez‐Festa, Alejandro, Calabuig‐Fariñas, Silvia, Molina‐Vila, Miguel Ángel, Provencio, Mariano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7782072/ https://www.ncbi.nlm.nih.gov/pubmed/33107189 http://dx.doi.org/10.1002/1878-0261.12832 |
Ejemplares similares
-
NGS‐based liquid biopsy profiling identifies mechanisms of resistance to ALK inhibitors: a step toward personalized NSCLC treatment
por: Sánchez‐Herrero, Estela, et al.
Publicado: (2021) -
MicroRNAs: Promising New Antiangiogenic Targets in Cancer
por: Gallach, Sandra, et al.
Publicado: (2014) -
Prognostic value of quantitative ctDNA levels in non small cell lung cancer patients
por: Provencio, Mariano, et al.
Publicado: (2017) -
Overall Survival and Biomarker Analysis of Neoadjuvant Nivolumab Plus Chemotherapy in Operable Stage IIIA Non–Small-Cell Lung Cancer (NADIM phase II trial)
por: Provencio, Mariano, et al.
Publicado: (2022) -
MicroRNA profiling associated with non-small cell lung cancer: next generation sequencing detection, experimental validation, and prognostic value
por: Gallach, Sandra, et al.
Publicado: (2017)